In the meta-analysis, while the general and stratified by ethnicity analyses showed that the association between CD14 260 C/T and the development of GC was not statistically significant, sensitivity analysis excluding the study by Zhao et al. [52], the only study that did not specify tumour location, provided borderline results inferring that the CD14 -260 T allele might be a protective factor against the development of non-cardia GC mainly, the main GC subtype in East Asian populations including our ethnic Chinese population. This evidence concerns the gene CD14 and gastric cancer.